The late accumulation of high numbers of CD25+Foxp3+ Tregs cells (D14) in the DLN of treated mice indicates that Tregs suppressive effects are likely to occur mainly at the initial phase of the anti-tumour response. The gene discussed is FOXP3; the disease is neoplasm.